Description
The Rocky Mountain Regional VA Medical Center requires Inhaled Nitric Oxide (INO) therapy for critically ill patients. The requirement is for a base year with four one-year options. The therapy provides an hourly inhaled nitric oxide pharmaceutical gas to reduce pulmonary hypertension by way of vasodilation. It is also a treatment for acute respiratory distress syndrome (ARDS). The mechanism of delivery is INO vent in line with an invasive ventilator. INO Therapeutics LLC is the sole provider of the required INOmax.
• The requirement is for a base year with four one-year options.
• The therapy provides an hourly inhaled nitric oxide pharmaceutical gas.
• The mechanism of delivery is INO vent in line with an invasive ventilator.
• INO Therapeutics LLC is the sole provider of the required INOmax.